Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 10, Pages 1267-1270
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-03-05
DOI
10.1200/jco.2012.46.9403
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Multifactorial Likelihood Model for MMR Gene Variant Classification Incorporating Probabilities Based on Sequence Bioinformatics and Tumor Characteristics: A Report from the Colon Cancer Family Registry
- (2012) Bryony A. Thompson et al. HUMAN MUTATION
- SIFT web server: predicting effects of amino acid substitutions on proteins
- (2012) Ngak-Leng Sim et al. NUCLEIC ACIDS RESEARCH
- A Computational Method to Classify Variants of Uncertain Significance Using Functional Assay Data with Application to BRCA1
- (2011) E. S. Iversen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic testing and cancer risk management recommendations by physicians for at-risk relatives
- (2011) Sharon E Plon et al. GENETICS IN MEDICINE
- Personalized medicine: new genomics, old lessons
- (2011) Kenneth Offit HUMAN GENETICS
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes
- (2011) Amanda B. Spurdle et al. HUMAN MUTATION
- A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)
- (2011) Noralane M. Lindor et al. HUMAN MUTATION
- Long-Term Reactions to Genetic Testing for BRCA1 and BRCA2 Mutations: Does Time Heal Women's Concerns?
- (2011) Chanita Hughes Halbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
- (2011) Anita Villani et al. LANCET ONCOLOGY
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CHEK2, breast cancer, and the understanding of clinical utility
- (2010) M Robson CLINICAL GENETICS
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
- (2010) Susan M. Domchek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
- (2010) Mark E. Robson et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Testing in Li-Fraumeni Syndrome: Uptake and Psychosocial Consequences
- (2010) Chantal R.M. Lammens et al. JOURNAL OF CLINICAL ONCOLOGY
- Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research
- (2010) R. C. Fitzgerald et al. JOURNAL OF MEDICAL GENETICS
- Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers
- (2010) K. A. Schrader et al. JOURNAL OF MEDICAL GENETICS
- Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing
- (2010) Tom Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review.
- (2009) Jada G. Hamilton et al. HEALTH PSYCHOLOGY
- Time to Check CHEK2 in Families With Breast Cancer?
- (2008) Kenneth Offit et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started